A study of nearly 28,000 23andMe users who reported taking GLP-1 weight-loss medications, published in Nature, found that a mutation in GLP1R, the gene encoding the protein targeted by GLP-1 drugs, was modestly but significantly associated with greater weight loss
Previous research showed that lower SES is consistently associated with an increased risk of OSA in both adults and children
reported that H 2 O 2 inhibited HBV replication in human hepatoma cell lines in a p53-dependent manner 87
What to know about cheaper, imitation weight-loss drugs, The Washington Post, July 18, 2024 Why Millions Are Trying FDA-Authorized Alternatives to Big Pharmas Weight Loss Drugs, KFF Health News, July 23, 2024
PubMed+1 Ryan DH, et al
Available from URL: (accessed January 2026) Sterne JA, Savovi J, Page MJ, et al